Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH)

Rigshospitalet, Copenhagen

Aarhus Universitetshospital, Aarhus

Radboudumc, Nijmegen

University of Rochester Medical Center, Rochester

Hospital Universitario Donostia, San Sebastián

Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan

Fondazione Serena Onlus- Centro Clinico NEMO, Milan

Kennedy Krieger Institute, Baltimore

Virginia Commonwealth University, Richmond

University of Florida, Gainesville

Ohio State University Medical Center, Columbus

Hospital Universitari i Politecnic La Fe, Valencia

University Hospital Bonn, Bonn

Mayo Clinic, Rochester

Washington University School of Medicine, St Louis

University of Kansas Medical Center, Kansas City

Institute de Myologie, Groupe Hospitalier Pitié-Salpêtrière, Paris

University of Colorado Anschutz Medical Campus, Aurora

LMU Klinikum Ludwig-Maximilians-Universität München, München

University of Utah, Salt Lake City

Universitätsklinikum Ulm, Ulm

University of California Los Angeles (UCLA), Los Angeles

University of California Irvine, Irvine

University of Washington Medical Center, Seattle

University of Massachusetts Memorial Medical Center, Worcester

University of Calgary, Calgary

The Ottawa Hospital Research Institute, Ottawa

Montreal Neurological Institute and Hospital, Montreal

Nice University Hospital - CHU Nice, Nice

Leiden University Medical Centre, Leiden

Hospital Universitario Vall d'Hebron, Barcelona

University College of London Hospitals, London

Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne